The medicine Enhertu was approved by the FDA in 2019 for the treatment of patients who have unresectable or metastatic HER2-positive breast cancer and locally advanced or metastatic HER2-positive gastric or gastroesophageal junction adenocarcinoma. Enhertu contains Trastuzumab Deruxtecan, a HER2-directed antibody, and topoisomerase inhibitor conjugate. The antibody is produced in Chinese hamster ovary cells by recombinant DNA technology, and the topoisomerase inhibitor and linker are produced by chemical synthesis. This medicine is supplied in 100 mg single-dose vials to administer intravenously. The active ingredient in the medicine is Trastuzumab Detuxtecan with inactive ingredients L-histidine, L-histidine hydrochloride monohydrate, polysorbate 80, and sucrose. This medicine is used in treating patients with unresectable or metastatic HER2-positive breast cancer. There are numerous licensed pharmaceutical Suppliers of Enhertu in India and one can easily purchase this medicine at reasonable prices. To know more about Enhertu, ring us at 18008891064.
Enhertu: Know about Medication
Enhertu Suppliers in India | 9310090915 | Buy Enhertu Injection.